Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 19 studies | 45% ± 14% | |
lung | 18 studies | 44% ± 15% | |
intestine | 12 studies | 41% ± 16% | |
brain | 10 studies | 29% ± 11% | |
kidney | 9 studies | 42% ± 10% | |
eye | 9 studies | 41% ± 20% | |
bone marrow | 6 studies | 34% ± 9% | |
liver | 6 studies | 40% ± 18% | |
pancreas | 5 studies | 63% ± 25% | |
lymph node | 5 studies | 44% ± 8% | |
placenta | 4 studies | 46% ± 24% | |
uterus | 4 studies | 54% ± 15% | |
prostate | 4 studies | 29% ± 9% | |
breast | 4 studies | 46% ± 8% | |
adrenal gland | 3 studies | 35% ± 8% | |
thymus | 3 studies | 51% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3141.35 | 1445 / 1445 | 100% | 40.62 | 183 / 183 |
ovary | 100% | 3026.16 | 180 / 180 | 100% | 71.20 | 430 / 430 |
pancreas | 100% | 4162.77 | 328 / 328 | 100% | 56.96 | 178 / 178 |
prostate | 100% | 3448.91 | 245 / 245 | 100% | 80.56 | 502 / 502 |
stomach | 100% | 3824.89 | 359 / 359 | 100% | 60.15 | 286 / 286 |
brain | 100% | 3192.23 | 2638 / 2642 | 100% | 63.41 | 705 / 705 |
thymus | 100% | 4202.55 | 653 / 653 | 100% | 74.69 | 604 / 605 |
lung | 100% | 3133.22 | 577 / 578 | 100% | 53.33 | 1155 / 1155 |
intestine | 100% | 3449.14 | 966 / 966 | 100% | 62.85 | 526 / 527 |
skin | 100% | 4017.11 | 1809 / 1809 | 100% | 81.70 | 471 / 472 |
uterus | 100% | 3284.36 | 170 / 170 | 100% | 56.37 | 458 / 459 |
liver | 100% | 3122.58 | 226 / 226 | 100% | 63.86 | 405 / 406 |
bladder | 100% | 3499.86 | 21 / 21 | 100% | 75.68 | 502 / 504 |
breast | 100% | 3519.93 | 459 / 459 | 100% | 75.64 | 1113 / 1118 |
kidney | 100% | 4165.54 | 89 / 89 | 99% | 41.48 | 892 / 901 |
adrenal gland | 100% | 5083.52 | 258 / 258 | 98% | 62.75 | 226 / 230 |
adipose | 100% | 3151.94 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 45.46 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 64.36 | 29 / 29 |
spleen | 100% | 3556.61 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 46.49 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 59.23 | 1 / 1 |
blood vessel | 100% | 3897.42 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 2769.10 | 801 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 3532.28 | 908 / 929 | 0% | 0 | 0 / 0 |
heart | 97% | 2600.94 | 839 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006465 | Biological process | signal peptide processing |
GO_0045047 | Biological process | protein targeting to ER |
GO_0019082 | Biological process | viral protein processing |
GO_0006508 | Biological process | proteolysis |
GO_0019068 | Biological process | virion assembly |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005787 | Cellular component | signal peptidase complex |
GO_0005515 | Molecular function | protein binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | SPCS1 |
Protein name | Signal peptidase complex subunit 1 (Microsomal signal peptidase 12 kDa subunit) Signal peptidase complex subunit 1 (Microsomal signal peptidase 12 kDa subunit) (SPase 12 kDa subunit) |
Synonyms | SPC12 HSPC033 |
Description | FUNCTION: Component of the signal peptidase complex (SPC) which catalyzes the cleavage of N-terminal signal sequences from nascent proteins as they are translocated into the lumen of the endoplasmic reticulum . Dispensable for SPC enzymatic activity (By similarity). .; FUNCTION: (Microbial infection) Required for the post-translational processing of proteins involved in virion assembly and secretion from flaviviruses such as West Nile virus (WNV), Japanese encephalitis virus (JEV), Dengue virus type 2 (DENV-2), Yellow Fever virus (YFV), Zika virus (ZIKV) and hepatitis C virus (HCV) . Plays a key role in the post-translational processing of flaviviral structural proteins prM, E, and NS1 . In HCV, it is involved in virion assembly where it promotes the interaction between HCV virus proteins NS2 and E2 . . |
Accessions | Q9Y6A9 ENST00000233025.11 C9JBL1 ENST00000423431.5 ENST00000619898.5 A0A5F9YFS9 |